Phychem Technologies IPO Opens August 31
Phychem Technologies Limited is preparing to enter the SME market, with its IPO scheduled to open on August 31, 2026, and close on September 2, 2026.
The company has fixed a price band of ₹51 to ₹54 per equity share. The issue is structured as a 100% fresh issue, with no Offer for Sale component. Shares are proposed to list on the BSE SME platform on September 7, 2026.
Phychem Technologies IPO Details
| Particular | Details |
|---|---|
| IPO Open Date | August 31, 2026 |
| IPO Close Date | September 2, 2026 |
| Price Band | ₹51 – ₹54 |
| Face Value | ₹10 per share |
| Lot Size | 2,000 Shares |
| Retail Minimum | 4,000 Shares |
| Minimum Investment | ₹2.16 Lakh |
| Issue Type | Fresh Issue |
| OFS | Nil |
| Listing Exchange | BSE SME |
| Allotment | September 3, 2026 |
| Listing Date | September 7, 2026 |
Current trackers differ slightly on the final issue amount, reporting roughly ₹14–₹15 crore, so the offer document/exchange figure should be treated as final. The ₹51–₹54 price band, August 31 opening and September 7 listing schedule are consistently reported.
What Does Phychem Technologies Do?
Phychem Technologies operates in the plastic and polymer manufacturing industry.
The company manufactures specialised polymer and plastic compounds used as industrial raw materials. This places it primarily in the B2B manufacturing segment, where product quality, formulation capabilities, customer relationships and cost efficiency play important roles.
Its registered operations are based in Nashik, Maharashtra.
FY2026 Profit Shows Strong Growth
Phychem's latest financial performance shows a steady increase in revenue but a much faster improvement in profitability.
| Financial Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Revenue from Operations | ₹46.97 Cr | ₹50.30 Cr | ₹56.47 Cr |
| PAT | ₹1.69 Cr | ₹2.84 Cr | ₹4.09 Cr |
| Net Worth | ₹6.86 Cr | ₹9.70 Cr | ₹13.79 Cr |
| Borrowings | ₹5.61 Cr | ₹4.59 Cr | ₹5.91 Cr |
Revenue increased by approximately 12.3% in FY2026, while PAT jumped by around 44% from ₹2.84 crore to ₹4.09 crore.
The faster increase in earnings compared with revenue is an important point for investors because it indicates improving profitability as the business scales.
IPO Money to Fund New Plant and Machinery
A major objective of the IPO is manufacturing investment.
Phychem Technologies plans to use approximately ₹4.86 crore of the proceeds toward purchasing new plant and machinery.
For a manufacturing company, new equipment can support higher production capacity, improve efficiency and potentially allow the company to handle a larger customer base.
However, the benefit will ultimately depend on how effectively the company utilises the additional machinery after installation.
₹3 Crore Planned for Debt Repayment
The company also intends to allocate approximately ₹3 crore toward repayment or prepayment of existing borrowings.
Another approximately ₹3 crore is planned for working-capital requirements.
This combination is significant because Phychem is using IPO capital for both expansion and balance-sheet support.
Reducing debt can lower future interest expenses, while additional working capital can help support larger production volumes.
Working Capital Will Matter as Business Expands
Manufacturing businesses need capital to purchase raw materials, maintain inventory and manufacture products before receiving customer payments.
If Phychem's revenue grows following its machinery expansion, its working-capital requirements could also increase.
The planned ₹3 crore allocation can therefore provide additional liquidity for day-to-day operations.
After listing, investors should monitor whether higher sales translate into stronger operating cash flow, rather than simply creating larger receivables and inventories.
Improving Return Ratios
Phychem's latest IPO data indicates a Return on Net Worth of around 29.3%.
At the upper price band, one current calculation places the IPO valuation at approximately 19.4 times post-issue earnings.
There are also no directly comparable listed Indian peers identified in the available IPO comparison data, which can make relative valuation more difficult.
Investors therefore need to evaluate the company's valuation largely against its own growth, margins and return ratios.
Fresh Issue Is a Positive Structural Point
The IPO does not contain an OFS component.
That means the money raised through the fresh issue, after IPO expenses, goes into Phychem Technologies rather than providing an exit to existing shareholders.
The capital is being directed primarily toward plant and machinery, debt repayment and working capital, giving the issue a relatively clear capital-deployment plan.
Raw-Material Prices Remain an Important Risk
Polymer and plastic manufacturers can be sensitive to changes in raw-material prices.
If input costs increase rapidly and the company cannot pass those increases on to customers, profit margins can come under pressure.
Phychem's recent improvement in PAT is encouraging, but maintaining these margins as production expands will be more important than one year's earnings growth.
Capacity Expansion Needs Customer Demand
Additional manufacturing capacity can support growth only if customer demand also increases.
New machinery brings depreciation, maintenance and operating expenses.
Phychem therefore needs to generate sufficient additional orders to achieve healthy utilisation of its expanded manufacturing setup.
This will be one of the key indicators to monitor over the first few years after listing.
Phychem Technologies GMP Today
The latest available grey-market data shows Phychem Technologies IPO GMP at ₹0, implying no unofficial premium over the ₹54 upper price band at present.
The IPO is still several days away from opening, so grey-market activity can change.
GMP is unofficial and unregulated and should not be considered a guaranteed indication of listing performance.
What Looks Positive?
Phychem Technologies enters the IPO with improving financial performance.
Revenue from operations increased from ₹46.97 crore in FY2024 to ₹56.47 crore in FY2026, while PAT more than doubled from ₹1.69 crore to ₹4.09 crore over the same period.
The IPO is also entirely fresh issue, and proceeds are being deployed into identifiable growth and balance-sheet requirements.
New machinery could provide additional production capacity, while debt repayment could reduce financial pressure.
Key Risks to Watch
Phychem remains a relatively small manufacturing company, making individual customers, raw-material movements and changes in demand potentially more significant to overall financial performance.
Investors should also watch working-capital requirements, capacity utilisation and whether the recent improvement in profit margins remains sustainable.
Because the shares will list on BSE SME, lower post-listing liquidity and higher price volatility are additional considerations.
Final View on Phychem Technologies IPO
The Phychem Technologies IPO opens from August 31 to September 2, 2026, at a price band of ₹51–₹54 per share, with listing scheduled on BSE SME for September 7.
The company's recent financial trajectory is encouraging. FY2026 revenue from operations reached ₹56.47 crore, while PAT increased to ₹4.09 crore, compared with ₹2.84 crore in FY2025.
The IPO-funded investment in new plant and machinery, debt repayment and working capital could support the next stage of business growth.
For investors, the important factors to watch will be IPO valuation, capacity utilisation, raw-material costs, working-capital management and whether Phychem can sustain its recent improvement in profitability as the manufacturing business expands.
Loading comments...